Vivek Srivastava

Vivek Srivastava

Auto-generated profile, based on publicly available information

Vivek Srivastava

DIT University

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2014 in Journal of Materials Science
Verified
Journal Article
Closed access
PDF file
VSVivek Srivastava
Vivek Srivastava
RSRajeev Srivastava
Rajeev Srivastava

30 April 2021 in Journal of Medical Engineering & Technology
Verified
Journal Article
Closed access
AMAbhay Mishra
Abhay Mishra
VSVivek Srivastava
Vivek Srivastava
An implants’ effectiveness depends upon the form of biomaterial used in its manufacture. A suitable material for implants should be biocompatible, sterile, mechanically stable and simple to shape. 3D printing technologies have been breaking new ground in the medical and medical industries in order to build patient-specific devices embedded in bioactive drugs, cells and proteins. Widespread use in medical 3D printing is a broad range of biomaterials including metals, ceramics, polymers and composites. Continuous work and developments in biomaterials used in 3D printing have contributed to significant growth of 3D printing applications in the production of personalised joints, prostheses, medication delivery system and 3D tissue engineering and regenerative medicine scaffolds. The present analysis focuses on the biomaterials used for therapeutic applications in different 3D printing technologies. Many specific forms of medical 3D printing technology are explored in depth, including fused deposition modelling, extrusion-based bioprinting, inkjet and poly-jet printing processes, their therapeutic uses, various types of biomaterial used today and the major shortcoming , are being studied in depth.

19 March 2025 in International Journal on Interactive Design and Manufacturing (IJIDeM)
Verified
Journal Article
Closed access
PDF file
MCMayank Choubey
Mayank Choubey
KMKalipada Maity
Kalipada Maity
VSVivek Srivastava
Vivek Srivastava
PKPushpinder Kumar
Pushpinder Kumar

29 October 2020 in Journal of Medical Engineering & Technology
Verified
Journal Article
Closed access
DBDebojit Bhattacharjee
Debojit Bhattacharjee
VSVivek Srivastava
Vivek Srivastava
Three-dimensional (3D) printing is an additive manufacturing technique where objects are created under computer control. Apart from opening many avenues of manufacturing, 3D printing of medicine has become a lucrative area in research. The technology can deliver customised and effectively on-demand treatments for individuals with unique needs; drug delivery system capable of dispensing spatially accurate and low volumes of medicine; preparation of medicine comprised of complex composition and geometric shape. Advent of 3D printed drugs like Spritam® has been FDA approved which have heightened the hopes. Pharmaceutical industry at present is shifting from mass production to personalised medicine as it promises future production of on-demand printed drugs with customised doses, increased productivity and cost-effectiveness. The goal of this article is to outline and explore the various approaches, along with the key aspects of drug printing, and also allow space for exploration of the main areas of 3D printing to be tackled in the future in order to make it an effective manufacturing route for the pharmaceutical industry.

9 September 2022
Verified
Book Chapter
Closed access
PDF file
DBDebojit Bhattacharjee
Debojit Bhattacharjee
VSVivek Srivastava
Vivek Srivastava
NGNitin Gupta
Nitin Gupta

9 September 2022
Verified
Book Chapter
Closed access
PDF file
VSVivek Srivastava
Vivek Srivastava
OROjas Raturi
Ojas Raturi